- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Parotid Gland Disorders in Russian Federation
Total 1963 results
-
R-PharmSynergy Research Inc.CompletedAlcohol DependenceRussian Federation, Kazakhstan
-
SanofiCompletedHypercholesterolemiaRussian Federation, Turkey, Mexico, Hungary, Korea, Republic of, Chile
-
AstraZenecaRecruiting
-
Rovi Pharmaceuticals LaboratoriesCompletedFoot Ulcer, DiabeticCroatia, Poland, Romania, Russian Federation, Serbia, Spain
-
AbbottManipal Acunova Ltd.CompletedDepressionRussian Federation
-
Eli Lilly and CompanyCompletedBipolar DisorderHungary, Australia, Greece, Russian Federation
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Poland, Romania, Russian Federation, Ukraine, India, Belgium, Mexico, Tunisia, Japan, Israel, Korea, Republic of
-
Hoffmann-La RocheCompleted
-
AbbVie (prior sponsor, Abbott)AlmedisCompletedSecondary HyperparathyroidismRussian Federation
-
Janssen Research & Development, LLCCompletedB-Cell Chronic Lymphocytic LeukemiaSpain, Russian Federation, Canada
-
AstraZenecaCompletedPuberty, PrecociousUnited States, Canada, Russian Federation, France, India, United Kingdom
-
Catalyst BiosciencesCompletedHemophilia A With Inhibitor | Hemophilia B With InhibitorArmenia, Georgia, South Africa, Poland, Russian Federation
-
Abbott NutritionTerminatedAcute Lung Injury | Respiratory Distress Syndrome,AdultRussian Federation
-
BayerCompletedErectile DysfunctionKorea, Republic of, Saudi Arabia, Singapore, Kazakhstan, Lebanon, Russian Federation, Ukraine, Egypt, Israel, Kyrgyzstan
-
Hoffmann-La RocheTerminatedLymphocytic Leukemia, ChronicRussian Federation
-
BiocadCompletedChemotherapy-induced NeutropeniaRussian Federation
-
BiocadRecruitingHemophilia ARussian Federation
-
American Regent, Inc.CompletedIron Deficiency Anemia (IDA)Poland, Russian Federation
-
SanofiTerminatedDiabetes Mellitus, Type 2United States, Poland, Romania, Russian Federation, Ukraine, Malaysia, Philippines, Taiwan, Mexico, Lithuania, Slovakia, Indonesia, Thailand
-
AstraZenecaBristol-Myers SquibbCompleted
-
GlaxoSmithKlineCompletedDepressive Disorder, MajorBelgium, Australia, Russian Federation, Netherlands, Norway, Finland
-
BayerWithdrawnHypogonadismRussian Federation, Italy, Latvia, Poland, Germany, United Kingdom
-
BioprojetActive, not recruitingNarcolepsy Without Cataplexy | Narcolepsy With CataplexyFrance, Italy, Russian Federation, Finland, Netherlands
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Spain, China, India, Russian Federation, Turkey, Germany, Japan, United Kingdom, France, United States
-
NeuromaxBioneviaCompletedDiabetic Peripheral NeuropathyRussian Federation
-
ShireCompletedGaucher Disease, Type 1Israel, Paraguay, Argentina, Russian Federation, Tunisia
-
Eli Lilly and CompanyTerminatedDiabetes Mellitus, Type 2Russian Federation, Spain, Germany, Australia, Austria, Israel, Czech Republic
-
TakedaCompletedHypercholesterolemiaSerbia, Estonia, Russian Federation, Latvia
-
SanofiCompletedType 2 Diabetes MellitusFrance, Russian Federation, United States, Argentina, Canada, Germany, South Africa, Italy, Netherlands, United Kingdom, Australia, Chile
-
SanofiCompletedDepressive Disorder | Major DepressionFrance, Poland, Romania, Russian Federation, Bulgaria, Serbia, Slovakia, Czech Republic, Mexico, Argentina, Croatia, Finland, South Africa
-
AbbVie (prior sponsor, Abbott)CompletedAlzheimer's DiseaseRussian Federation, Ukraine
-
PfizerTerminatedDepressive Disorder, MajorUnited States, Former Serbia and Montenegro, Russian Federation
-
Materia Medica HoldingCompletedAnxietyRussian Federation, Kazakhstan
-
Catalysis SLCompletedNon-small Cell Lung Cancer Stage III | Gastric Cancer Stage III | Gastric Cancer Stage II | Non-small Cell Lung Cancer Stage IIKazakhstan, Russian Federation
-
TakedaCompletedPost-Stroke Cognitive Impairment (PSCI)Belarus, Kazakhstan, Russian Federation
-
Halozyme TherapeuticsCompletedStage IV Pancreatic CancerUnited States, Russian Federation
-
Janssen Research & Development, LLCCompletedMultiple Myeloma | Monoclonal Gammopathy of Undetermined Significance | Plasma Cell NeoplasmUnited States, Belgium, Russian Federation
-
AstraZenecaRecruiting
-
NovartisCompletedDiabetes Mellitus, Type 2Spain, Argentina, Russian Federation, Norway, India, Sweden, Finland, France, Canada, Germany, Australia, Costa Rica
-
BayerCompletedEndometriosisSaudi Arabia, Jordan, Kazakhstan, Lebanon, Russian Federation, Ukraine, Egypt, United Arab Emirates, Kuwait, Qatar, Belarus
-
TakedaCompletedHemophilia ARussian Federation
-
AstraZenecaRUSSCO (Russian Society of Clinical Oncology)CompletedOvarian, Peritoneal, Fallopian Tube Cancer, BRCAm+ in RussiaRussian Federation
-
SanofiTerminatedDiabetes Mellitus, Type 2United States, Romania, Russian Federation, Spain, Sweden, India, Mexico, Denmark, Finland, Hungary, Italy, Korea, Republic of, Chile, Puerto Rico
-
CytokineticsCompletedNon-Hodgkin's Lymphoma | Hodgkin's DiseaseUnited States, Russian Federation
-
TakedaCompletedDiabetes MellitusRussian Federation
-
SanofiCompletedSleep Initiation and Maintenance DisordersUnited States, France, Russian Federation, Germany, Austria, Canada, Australia
-
Baxter Healthcare CorporationCompletedDiabetes | ESRD | CAPD | APDTaiwan, Korea, Republic of, Singapore, Hong Kong, Russian Federation
-
Materia Medica HoldingCompletedCognitive DisordersRussian Federation
-
IpsenCompletedStroke, Acute | Neurological ImpairmentCzechia, Poland, Romania, Russian Federation
-
Affimed GmbHTerminatedLeukemia, B-CellAustria, Israel, Russian Federation, Poland, Czechia